NEUTROPEG pegfilgrastim 6 mg/0.6 mL solution for injection pre-filled syringe

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

Pegfilgrastim, Quantity: 6 mg

Disponible depuis:

Accord Healthcare Pty Ltd

forme pharmaceutique:

Injection, solution

Composition:

Excipient Ingredients: glacial acetic acid; polysorbate 20; sodium hydroxide; sorbitol; water for injections

Mode d'administration:

Subcutaneous

Unités en paquet:

1 prefilled syringe

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

For the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia and so reduce the incidence of infection, as manifested by febrile neutropenia.

Descriptif du produit:

Visual Identification: clear and colourless liquid; Container Type: Syringe; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statut de autorisation:

Registered

Date de l'autorisation:

2019-08-19